Maat Pharma (XPAR:MAAT) FCF Margin % : -719.06% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Maat Pharma FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Maat Pharma's Free Cash Flow for the six months ended in Dec. 2023 was €-6.11 Mil. Maat Pharma's Revenue for the six months ended in Dec. 2023 was €0.85 Mil. Therefore, Maat Pharma's FCF Margin % for the quarter that ended in Dec. 2023 was -719.06%.

As of today, Maat Pharma's current FCF Yield % is -18.11%.

The historical rank and industry rank for Maat Pharma's FCF Margin % or its related term are showing as below:

XPAR:MAAT' s FCF Margin % Range Over the Past 10 Years
Min: -927.76 Med: -887.03 Max: -840.23
Current: -887.03

During the past 6 years, the highest FCF Margin % of Maat Pharma was -840.23%. The lowest was -927.76%. And the median was -887.03%.

XPAR:MAAT's FCF Margin % is ranked worse than
74.71% of 1044 companies
in the Biotechnology industry
Industry Median: -139.2 vs XPAR:MAAT: -887.03

Maat Pharma FCF Margin % Historical Data

The historical data trend for Maat Pharma's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Maat Pharma FCF Margin % Chart

Maat Pharma Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-840.23

-927.76

-887.03

Maat Pharma Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial					-613.29	-1,460.53	-646.58	-990.64	-719.06

Competitive Comparison of Maat Pharma's FCF Margin %

For the Biotechnology subindustry, Maat Pharma's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Maat Pharma's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Maat Pharma's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Maat Pharma's FCF Margin % falls into.

Maat Pharma FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Maat Pharma's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-19.763	/	2.228
	=	-887.03 %

Maat Pharma's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-6.112	/	0.85
	=	-719.06 %

Maat Pharma FCF Margin % Related Terms

Thank you for viewing the detailed overview of Maat Pharma's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Maat Pharma (XPAR:MAAT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Maat Pharma SA (XPAR:MAAT) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

4RD:Germany

Address

70 Avenue Tony Garnier, Lyon, FRA, 69007

Website

https://www.maatpharma.com

Maat Pharma SA is a french clinical stage biotech and a pioneer in the development of microbiome based ecosystem therapies dedicated to improving survival outcomes for patients with cancer.

Maat Pharma (XPAR:MAAT) Headlines

No Headlines